Stryker Corporation (SYK)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $117.88B
Last updated: Nov 17, 2026 at 11:06 AM ET
Stryker Corporation (SYK) Stock Forecast
Analysts expect Stryker (SYK) to earn $14.83 per share in the fiscal year ending Dec 31, 2026, on revenue of $26.81B. Of 30 analysts, 22 rate the stock Buy or Strong Buy, 8 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $16.29.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 30 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 73% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 8 | 26.7% |
| Buy | 14 | 46.7% |
| Hold | 8 | 26.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 30
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.8% and revenue estimates rise 7.1%.
- Fiscal year ending Dec 31, 2026
- $14.83
- EPS consensus, revenue $26.81B
- Fiscal year ending Dec 31, 2027
- $16.29
- EPS consensus, revenue $28.72B
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $14.83 | $14.80 to $14.88 | 29 | $26.81B | $26.70B to $26.90B | 27 |
| Dec 31, 2027 | $16.29 | $16.00 to $16.51 | 29 | $28.72B | $28.32B to $30.98B | 28 |
Quarterly Estimates
The EPS consensus falls from $5.06 for the quarter ending Dec 31, 2026 to $3.18 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.06 | $4.55 to $5.30 | 28 | $7.76B | $7.42B to $8.16B | 28 |
| Mar 31, 2027 | $3.18 | $2.83 to $3.63 | 16 | $6.52B | $6.41B to $6.68B | 14 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 29 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 0 | 20 |
| Quarter ending Mar 31, 2027 | 1 | 9 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 1.3% from $15.02.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $14.83 | $14.83 | $14.97 | $15.01 | $15.02 | -1.2% |
| Fiscal year ending Dec 31, 2027 | $16.29 | $16.31 | $16.70 | $16.74 | $16.76 | -2.8% |
| Quarter ending Mar 31, 2027 | $3.18 | $3.18 | $3.28 | $3.29 | $3.30 | -3.7% |
Frequently Asked Questions About SYK
What is the SYK stock forecast?
Consensus analyst estimates put Stryker's EPS at $14.83 for the fiscal year ending Dec 31, 2026, on revenue of $26.81B. The consensus rating from 30 analysts is Buy.
How do analysts rate SYK stock?
Of 30 analysts covering Stryker, 8 rate it Strong Buy, 14 Buy, 8 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SYK next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $14.83, with estimates from $14.80 to $14.88 from 29 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $16.29, with estimates from $16.00 to $16.51 from 29 analysts.
What revenue do analysts expect from Stryker next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $26.81B, with estimates from $26.70B to $26.90B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $28.72B, with estimates from $28.32B to $30.98B.
How many analysts cover SYK?
30 analysts rate Stryker stock, and 29 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SYK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts